评价依达拉奉应用在急性脑梗塞患者治疗当中所取得的治疗效果
|
摘要
目的分析评价依达拉奉应用在急性脑梗塞患者治疗中所取得的治疗效果。方法选取自2016年8月至2018年8月我院收治的120例急性脑梗塞患者为观察对象,应用数字随机法将所有患者分为两组,即对照组(n=60)与观察组(n=60),针对对照组患者以常规方式进行治疗,针对观察组患者可在常规治疗基础上给予依达拉奉治疗,对比两组患者在经治疗后的临床效果。结果相比较对照组患者,观察组在治疗后临床总有效率更高,且NIHSS与ADL评分较之对照组有明显改善,组间比较差异有统计学意义(P<0.05)。结论对急性脑梗塞患者在治疗中用药依拉达奉,可提高临床治疗效果,改善患者神经功能与生活质量,值得在临床治疗中应用。
Objective To evaluate the therapeutic effect of edaravone in the treatment of patients with acute cerebral infarction.Methods A total of 120 patients with acute cerebral infarction admitted to our hospital from August 2016 to August 2018 were enrolled. All patients were divided into two groups by digital randomization method: control group(n=60) and observation group(n=60),the patients in the control group were treated with conventional methods, and the patients in the observation group were given edaravone on the basis of conventional treatment, and the clinical effects of the two groups after treatment were compared. Results Compared with the control group, the total effective rate of the observation group was higher after treatment, and the NIHSS and ADL scores were significantly improved compared with the control group. The difference between the groups was statistically significant(P<0.05). Conclusion In the treatment of acute cerebral infarction patients, the use of iradavone can improve the clinical therapeutic effect, improve the neurological function and quality of life of patients, which is worthy of clinical application.
Objective To evaluate the therapeutic effect of edaravone in the treatment of patients with acute cerebral infarction.Methods A total of 120 patients with acute cerebral infarction admitted to our hospital from August 2016 to August 2018 were enrolled. All patients were divided into two groups by digital randomization method: control group(n=60) and observation group(n=60),the patients in the control group were treated with conventional methods, and the patients in the observation group were given edaravone on the basis of conventional treatment, and the clinical effects of the two groups after treatment were compared. Results Compared with the control group, the total effective rate of the observation group was higher after treatment, and the NIHSS and ADL scores were significantly improved compared with the control group. The difference between the groups was statistically significant(P<0.05). Conclusion In the treatment of acute cerebral infarction patients, the use of iradavone can improve the clinical therapeutic effect, improve the neurological function and quality of life of patients, which is worthy of clinical application.
引文
[1]张伟,颜津津,廖品君,等.尤瑞克林联合依达拉奉在急性脑梗死中治疗效果及对患者血清C反应蛋白水平和神经功能缺损影响[J].海峡药学,2016,28(6):192-193.
[2]孙可乐,王康.氯吡格雷联合依达拉奉对急性脑梗死的治疗效果[J].河南医学研究,2018,27(7):161-162.
[3]孙晓路.分析尤瑞克林联合依达拉奉对急性脑梗死的治疗效果[J].中国疗养医学,2018,27(4):414-415.
[4]冯建文.瑞舒伐他汀联合依达拉奉对急性脑梗死治疗效果及炎症因子的影响[J].中外医疗,2017,36(3):117-119.
[5]李雪莲.丁苯酞联合依达拉奉对急性脑梗死治疗效果探讨[J].中国继续医学教育,2016,8(33):183-184.
[6]张磊.探讨依达拉奉联合注射用丹参治疗急性脑梗塞效果观察[J].中医临床研究,2016,8(5):89-90.
[7]Liu Y,Yang L,Zhang S,et al.Therapeutic effect of Butylphthalide Injection in elderly patients with acute cerebral infarction and its influence in cerebral hemodynamics and cerebral vascular reserve[J].Journal of Jilin University,2017,43(2):344-348.
[8]陈芳.依达拉奉联合氯吡格雷、阿托伐他汀治疗急性脑梗死效果观察[J].现代实用医学,2016,28(2):221-223.
[9]翁瑞高.依达拉奉联合氯吡格雷治疗急性脑梗塞的系统评价[J].中外医疗,2016,35(36):113-114.
[10]庄源,徐文丽,安丽荣,等.急性脑梗塞采用高压臭氧与依达拉奉的治疗效果研究[J].中外医疗,2016,35(3):131-132.
[11]邵少举,王为民,李渊明,等.尤瑞克林联合依达拉奉治疗急性脑梗塞的效果探讨[J].中西医结合心血管病电子杂志,2016,4(9):158-159.
[12]Ke J,Jing M.Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction[J].Biomedical Reports,2016,5(2):155-158.
[13]吾木古丽苏穆·阿布都热西提,艾力江·依布拉音,艾赛提·乌布力喀斯木.依达拉奉联合盐酸法舒地尔治疗急性脑梗塞的临床疗效观察[J].转化医学电子杂志,2016,3(10):38-39.
[14]肖斌.依达拉奉治疗急性脑梗死的效果及对炎症因子与NIHSS评分的影响[J].中国实用神经疾病杂志,2016,19(7):59-60.
[15]欧阳葵,唐湘祁.长春西汀联合依达拉奉治疗急性脑梗死的临床效果及对患者神经功能恢复的影响[J].中国医学前沿杂志(电子版),2017,9(4):52-55.
[16]刘继男.依达拉奉联合早期康复治疗对急性脑梗死患者的临床效果分析[J].中国民康医学,2016,28(11):43-44.
[17]任广兰.探讨依达拉奉治疗急性脑梗死的临床效果观察[J].中国继续医学教育,2016,8(32):185-186.
[2]孙可乐,王康.氯吡格雷联合依达拉奉对急性脑梗死的治疗效果[J].河南医学研究,2018,27(7):161-162.
[3]孙晓路.分析尤瑞克林联合依达拉奉对急性脑梗死的治疗效果[J].中国疗养医学,2018,27(4):414-415.
[4]冯建文.瑞舒伐他汀联合依达拉奉对急性脑梗死治疗效果及炎症因子的影响[J].中外医疗,2017,36(3):117-119.
[5]李雪莲.丁苯酞联合依达拉奉对急性脑梗死治疗效果探讨[J].中国继续医学教育,2016,8(33):183-184.
[6]张磊.探讨依达拉奉联合注射用丹参治疗急性脑梗塞效果观察[J].中医临床研究,2016,8(5):89-90.
[7]Liu Y,Yang L,Zhang S,et al.Therapeutic effect of Butylphthalide Injection in elderly patients with acute cerebral infarction and its influence in cerebral hemodynamics and cerebral vascular reserve[J].Journal of Jilin University,2017,43(2):344-348.
[8]陈芳.依达拉奉联合氯吡格雷、阿托伐他汀治疗急性脑梗死效果观察[J].现代实用医学,2016,28(2):221-223.
[9]翁瑞高.依达拉奉联合氯吡格雷治疗急性脑梗塞的系统评价[J].中外医疗,2016,35(36):113-114.
[10]庄源,徐文丽,安丽荣,等.急性脑梗塞采用高压臭氧与依达拉奉的治疗效果研究[J].中外医疗,2016,35(3):131-132.
[11]邵少举,王为民,李渊明,等.尤瑞克林联合依达拉奉治疗急性脑梗塞的效果探讨[J].中西医结合心血管病电子杂志,2016,4(9):158-159.
[12]Ke J,Jing M.Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction[J].Biomedical Reports,2016,5(2):155-158.
[13]吾木古丽苏穆·阿布都热西提,艾力江·依布拉音,艾赛提·乌布力喀斯木.依达拉奉联合盐酸法舒地尔治疗急性脑梗塞的临床疗效观察[J].转化医学电子杂志,2016,3(10):38-39.
[14]肖斌.依达拉奉治疗急性脑梗死的效果及对炎症因子与NIHSS评分的影响[J].中国实用神经疾病杂志,2016,19(7):59-60.
[15]欧阳葵,唐湘祁.长春西汀联合依达拉奉治疗急性脑梗死的临床效果及对患者神经功能恢复的影响[J].中国医学前沿杂志(电子版),2017,9(4):52-55.
[16]刘继男.依达拉奉联合早期康复治疗对急性脑梗死患者的临床效果分析[J].中国民康医学,2016,28(11):43-44.
[17]任广兰.探讨依达拉奉治疗急性脑梗死的临床效果观察[J].中国继续医学教育,2016,8(32):185-186.